Cassava Sciences | PTIE - الدين





الدين تغيير تاريخ
Abbott USD 34.05B 20.19B 2026-03
Amgen USD 57.32B 2.72B 2026-03
Biogen USD 8.09B 1.53B 2026-06
Cara Therapeutics USD 0 0 2025-03
Cassava Sciences USD 0 0 2024-12
Eisai JPY 186.08B 50.58B 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Geron USD 122.07M 74K 2026-03
J&J USD 54.99B 7.05B 2026-03
Merck USD 49.12B 222M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 63.19B 536M 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06